These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7140170)

  • 1. [Therapy of pulmonary embolism with calcic heparin in subcutaneous administration].
    Leoncini B; Fabiano F; Coli A; Russo R
    Clin Ter; 1982 Jul; 102(1):41-58. PubMed ID: 7140170
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subcutaneous application of heparin in internal medicine].
    Losonezy H; Nagy I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):761-8. PubMed ID: 75145
    [No Abstract]   [Full Text] [Related]  

  • 4. [On pulmonary embolism--with a report on first experiences with subcutaneous heparin prophylaxis].
    Giehl HJ
    Dtsch Gesundheitsw; 1967 Sep; 22(39):1829-32. PubMed ID: 5600033
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems of heparin therapy].
    Makatsariia AD; Smolianitskiĭ AIa
    Klin Med (Mosk); 1980 Oct; 58(10):18-21. PubMed ID: 7003239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subcutaneous heparin treatment].
    Robertson B
    Nord Med; 1965 Oct; 74(40):994-7. PubMed ID: 5836667
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
    Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pulmonary embolism.
    Naina HV; Quevedo FJ
    N Engl J Med; 2008 Jun; 358(25):2745; author reply 2745-6. PubMed ID: 18572456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged anticoagulant treatment by subcutaneous injections of calcium heparinate].
    Demange J; Renais J; Scebat L; Lenegre J
    Presse Med (1893); 1967 Jun; 75(29):1499-502. PubMed ID: 6026886
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism.
    Minnema MC; ten Cate H; van Beek EJ; van den Ende A; Hack CE; Brandjes DP
    Thromb Haemost; 1997 Jun; 77(6):1164-7. PubMed ID: 9241751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of pulmonary embolism at our clinic following introduction of heparin therapy by small subcutaneous doses].
    Erdi A; Baranyai L
    Orv Hetil; 1978 Feb; 119(7):395-7. PubMed ID: 625413
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
    Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinzaparin: new indication. Easier treatment of less severe pulmonary embolism.
    Prescrire Int; 2002 Feb; 11(57):13-5. PubMed ID: 11985368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low dosage of heparin. Theoretical and practical evaluation].
    Gormsen J; Feddersen C; Clausen NT
    Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
    Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
    Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnosis, treatment and prevention of thromboembolism of the pulmonary artery in a general hospital].
    Ukolov VM; Rakov AL; Krashutskiĭ VV; Proskurin VM; Shepilov VV
    Voen Med Zh; 1995 Oct; (10):34-8. PubMed ID: 8533359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical effect of subcutaneous low-dose heparin].
    Andrassy T; Mayer W; Walz B
    Med Welt; 1981 May; 32(19):735-7. PubMed ID: 7231136
    [No Abstract]   [Full Text] [Related]  

  • 20. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.